Authors 

  Affiliation  ORCID ID 
Benjamin Jacob   Dept. of General Practice, RCSI University of Medicine and Health Sciences  0000-0003-1119-064X 
Heather Burns  HSE National Cancer Control Programme  0000-0003-3686-3898 
Barbara Clyne  Dept. of Public Health & Epidemiology, RCSI University of Medicine and Health Sciences  0000-0002-1186-9495 
Laura O’Connor  HRB Primary Care Clinical Trials Network   
Primary Care PPI Group  HRB Primary Care Clinical Trials Network   
Kathleen Bennett  Data Science Centre, RCSI University of Medicine and Health Sciences  0000-0002-2861-7665 
Patrick Redmond  Dept. of General Practice, RCSI University of Medicine and Health Sciences  0000-0002-3929-2018 

Keywords 

Stakeholder engagement; Patient and public involvement; Steering group; Primary care; Cancer research; Research funding; Ireland. 

Funding 

Benjamin Jacob was funded by a HSE/ICGP Post CSCST Fellowship Award to conduct this work. Barbara Clyne is funded by a Health Research Board (HRB) Emerging Investigator Award (EIA-2019–09). 

Conflict of interest 

None declared. 

Ethics 

The Research Ethics Committee at RCSI granted approval for this project (REC202301024) 

Abstract  

Introduction 

Currently, no group specifically supports and coordinates primary care focused cancer research in Ireland. The aim of this project is to establish an inclusive stakeholder group for primary care focused cancer research in Ireland, to coordinate research efforts and build capacity in researchers and institutions.  

Methods 

We will convene a stakeholder group, recruiting individuals with personal and professional experience of cancer care in a community setting. “Core stakeholders”—patients, clinicians, researchers, and policymakers—will attend regularly. Additional “specialist stakeholders”, such as representatives of secondary care, private healthcare, health insurance, industry, cancer charities, and health research funders, will participate on an ad hoc basis. 

An e-Delphi consensus process will be used to assess the stakeholders’ views on: (1) the relevance and importance of primary care focused cancer research; (2) the potential role and scope of the stakeholder group; (3) how best to engage with lived experience stakeholders and healthcare professionals affected by the research; (4) how best to disseminate results and advocate for translation of findings into practice. Round 1 will be open-ended and will invite the independent suggestions of stakeholders; in Round 2 and 3, group members will vote on the inclusion of these suggestions in a position statement by the group, with consensus defined as ≥75% agreement. 

Discussion 

The formation of a broad stakeholder group to support primary care focused cancer research will ensure research is relevant, patient centred, and more readily translated into practice. It is also hoped that the group will support capacity building and strategic planning in this important research space.